UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 16 filers reported holding UNICYCIVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,084 | -66.9% | 15,500 | 0.0% | 0.00% | -66.7% |
| Q1 2024 | $21,390 | +59.0% | 15,500 | 0.0% | 0.01% | +50.0% |
| Q4 2023 | $13,449 | -49.6% | 15,500 | -50.0% | 0.01% | -11.1% |
| Q3 2023 | $26,660 | +34.4% | 31,000 | +100.0% | 0.01% | -30.8% |
| Q2 2023 | $19,840 | -39.0% | 15,500 | 0.0% | 0.01% | -43.5% |
| Q1 2023 | $32,550 | +288.9% | 15,500 | 0.0% | 0.02% | +228.6% |
| Q4 2022 | $8,370 | -16.3% | 15,500 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $10,000 | -23.1% | 15,500 | 0.0% | 0.01% | -20.0% |
| Q2 2022 | $13,000 | -23.5% | 15,500 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $17,000 | -46.9% | 15,500 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $32,000 | -27.3% | 15,500 | 0.0% | 0.02% | -35.7% |
| Q3 2021 | $44,000 | – | 15,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rosalind Advisors, Inc. | 1,571,200 | $787,328 | 0.61% |
| Vivo Capital, LLC | 3,470,152 | $1,738,893 | 0.16% |
| Logos Global Management LP | 3,469,927 | $1,738,780 | 0.14% |
| Nantahala Capital Management | 2,820,358 | $1,413,282 | 0.08% |
| Monashee Investment Management LLC | 1,000,000 | $501,100 | 0.06% |
| BVF INC/IL | 2,200,000 | $1,102,420 | 0.03% |
| RA Capital Management | 2,632,200 | $1,318,995 | 0.02% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 15,500 | $7,084 | 0.00% |
| Scientech Research LLC | 10,969 | $5,497 | 0.00% |
| Redwood Wealth Management Group, LLC | 3,000 | $1,503 | 0.00% |